CFM
ORGO icon

Catalyst Funds Management’s Organogenesis Holdings ORGO Stock Holding History

Catalyst Funds Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,900
Closed -$54.4K – 512
2025
Q3 		$54.4K Sell
12,900
-4,300
-25% -$20K 0.01% 474
2025
Q2 		$63K Buy
+17,200
New +$64.1K 0.02% 354
2024
Q2 		– Sell
-66,610
Closed -$189K – 1483
2024
Q1 		$189K Buy
+66,610
New +$226K 0.05% 274

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Catalyst Funds Management's ORGO Position: Q4 2025 in Review

Catalyst Funds Management sold out of Organogenesis Holdings (ORGO) in Q4 2025, closing a stake of 12,900 shares — an estimated $54.4K sold.

Catalyst Funds Management first reported a position in ORGO in Q1 2024 and held it in 3 quarters. The position peaked at $189K in Q1 2024. 147 funds tracked by Wall St. Rank hold ORGO as of Q4 2025.

  • Catalyst Funds Management reported no remaining Organogenesis Holdings position as of Q4 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 12,900 Organogenesis Holdings shares in Q4 2025, an estimated $54.4K.
  • Catalyst Funds Management first reported a position in Organogenesis Holdings in Q1 2024 and held it in 3 quarters.
  • Catalyst Funds Management's Organogenesis Holdings position peaked at $189K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2025.

Based on Catalyst Funds Management's 13F filing for Q4 2025, filed 9 Feb 2026.